The Independent Voice of
European Private Equity

Advanced Search

Summa Equity buys proteomic company

Samantha Birchall 12 March 2019

Summa Equity has acquired a majority stake in the Swedish life science company, Olink Proteomics. Summa invests in sustainable companies that solve global problems.

Olink

Next article »

« Previous article

Related Articles

VC performance hits new high

23/07/19

Waterland-backed Median makes two deals

23/07/19

LBO France makes investment in Ecritel

23/07/19

Agilitas-backed Hydro makes second bolt-on

23/07/19

Innova Capital buys Optiplaza

23/07/19

Maven invests in computing company ebb3

23/07/19